Cargando…
DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response
BACKGROUND: As a leading cause of respiratory disease, influenza A virus (IAV) infection remains a pandemic threat in annual seasonal outbreaks. Given the limitation of existing anti-influenza therapeutic drugs, development of new drugs is urgently required. Flavonoids extracted from Artemisia rupes...
Autores principales: | Zhong, Ming, Wang, Huiqiang, Ma, Linlin, Yan, Haiyan, Wu, Shuo, Gu, Zhengyi, Li, Yuhuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381609/ https://www.ncbi.nlm.nih.gov/pubmed/30786886 http://dx.doi.org/10.1186/s12985-019-1125-9 |
Ejemplares similares
-
Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1
por: Yin, Jinqiu, et al.
Publicado: (2017) -
Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway
por: Yan, Haiyan, et al.
Publicado: (2018) -
Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT
por: CHEN, MING-HO, et al.
Publicado: (2012) -
Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy
por: Wang, Huiqiang, et al.
Publicado: (2017) -
C©đmo me qued©♭ calvo /
por: Grunberg, Arnon
Publicado: (2004)